Wikipedia

18p-

(Redirected from Chromosome 18, monosomy 18p)

18p-, also known as monosomy 18p, deletion 18p syndrome, del(18p) syndrome, partial monosomy 18p, or de Grouchy syndrome 1, is a genetic condition caused by a deletion of all or part of the short arm (the p arm) of chromosome 18. It occurs in about 1 of every 50,000 births.[1]

18p-
Other namesMonosomy 18p, deletion 18p syndrome, del(18p) syndrome, partial monosomy 18p, de Grouchy syndrome 1
4-month-old girl with cebocephaly as a result of 18p-
SpecialtyMedical genetics

Patients typically have petite frames, a short neck, and a distinctive stance. They may have mild microcephaly, a round, flat, expressionless face, a broad, flat nasal bridge, horizontal palpebral fissures, epicanthal folds, strabismus, and ptosis of the eyelids. The syndrome can lead to muscle hypotonia and a slowdown in activity and movements. Mental impairment is common, with an average intelligence quotient (IQ) ranging from 25 to 75. Holoprosencephaly (HPE) is the primary abnormality, characterized by aberrant development of the midface and forebrain. Severe brain anomalies are linked to facial traits, while milder variants may have minor facial abnormalities. Skeletal abnormalities, such as coxa vara, hip dislocation, scoliosis, and foot deformities, have been documented. Growth hormone (GH) insufficiency is often detected in individuals with short stature, and serum immunoglobulin A levels may be low or absent. Other conditions include alopecia areata, hypotrichosis simplex, and keratosis pilaris and ulerythema ophryogenes.

Cytogenetic study is crucial for a definitive diagnosis of 18p deletion syndrome, as phenotype alone cannot support the diagnosis. Typically, peripheral blood karyotype analysis is used, and can also come from trophoblast cells or amniocytes during the perinatal stage. Different syndromes, like Turner syndrome or trisomy 21, may be associated with 18p deletion.

Deletion 18p syndrome has no specific treatment but is often treated with speech therapy and physical therapy for hypotonia. Severe brain abnormalities lead to poor prognosis and neonatal death, while patients without severe abnormalities have a better chance of survival. Early rehabilitative and educational interventions are recommended.

Signs and symptoms

edit

18p- causes a wide range of medical and developmental concerns. There is significant variation in severity. This variation is due to the variability of the deletion size and breakpoints.[2]

Patients typically have petite frames, a short neck, and a distinctive stance in which they lean slightly forward while standing with their legs spread wide. There can be mild microcephaly present. Important traits include a round, flat, and expressionless face, a broad, flat nasal bridge, horizontal palpebral fissures, epicanthal folds, strabismus, and, when present, mostly ptosis of the eyelids. Ptosis may need to be surgically corrected and can be unilateral or bilateral. The lower lip is frequently everted, the mouth is large, the philtrum is somewhat short and projecting, and Cupid's bow is blunted with a flat upper lip. The palate may be highly arched, the lateral incisors are occasionally absent, and the poorly positioned teeth have severe caries. In children, the chin is little and somewhat receding; in adults, it becomes normal or even protrudes. Large and floppy, with disconnected pinnae and a hypoplastic anthelix, the ears are frequently low-set and turned posteriorly. The hands lack distinctive dermatoglyphics and are broad and short with phalanges that decline in width. Often indicative of Turner syndrome are a large chest with widely separated nipples or pectus excavatum, a short, occasionally webbed neck, and a low posterior hair line. Muscle hypotonia is a common condition. In most situations, puberty is normal, and conception is conceivable.[1]

Mental impairment is common. Although some individuals have been found to have normal or borderline mental development, the average intelligence quotient (IQ) ranges from 25 to 75, with most cases falling between 50 and 75. Verbal and motor abilities are often greatly dissociated, and speech delay is common.[1] There has been a noticeable slowdown in activity and movements.[3][4] Sometimes, behavioral traits like schizophrenia or autism exacerbate the mental illness.[1] Rarely are convulsive fits or electroencephalographic (EEG) abnormalities seen.[5]

Holoprosencephaly (HPE), the primary abnormality, is characterized by aberrant development of the midface and forebrain and is linked to a wide range of phenotypes.[6] Ten to fifteen percent of deletion 18p syndrome sufferers have severe brain anomalies linked to facial traits as cyplopia, cebocephaly, premaxillary agenesis, and bilateral cleft lip and palate.[7][8][9] In milder variants, there may or may not be a brain abnormality present along with minor facial abnormalities such as flat nasal bridge, hypo- or hypertelorism, agenesis of the corpus callosum, and absence of the olfactory pathways and bulbs.[1] In 18p-syndrome, a single central maxillary incisor has frequently been reported as an abortive type of holoprosencephaly.[10]

Numerous skeletal abnormalities, including coxa vara, hip dislocation, scoliosis and/or kyphosis, and foot deformities, have been documented. On rare occasions, males may have cryptorchidism and genital hypoplasia with a small penis.[1] About 10% of individuals had cardiac anomalies, which seemed to be a very uncommon occurrence, with situs abnormalities occurring in few situations.[11] Rarely or sporadically, a number of other abnormalities have been documented, most frequently for deletion 18p due to an imbalanced translocation and concurrent partial trisomy.[1]

Growth hormone (GH) insufficiency is often detected in people with short stature, which may support GH treatment.[12] Serum immunoglobulin A (IgA) levels may be low or absent.[13] There have been reports of juvenile diabetes, thyrotoxicosis, thyroiditis resulting in insufficiency,[14] and other auto-immune illnesses.[1]

There have been reports of alopecia areata, hypotrichosis simplex,[15][7] and other uncommon cutaneous conditions like keratosis pilaris and ulerythema ophryogenes.[16][17] A movement disorder called dystonia can manifest in early adulthood.[18][19]

Causes

edit

A single chromosome 18's short arm may be absent entirely or in part, resulting in deletion 18p syndrome. To find out if one parent has the unbalanced 18p- deletion or is a balanced translocation carrier, it is necessary to examine their parental karyotypes. About two thirds of cases include de novo deletions.[1]

In majority of the other cases that have been documented, the cause is an imbalanced whole arm translocation, which typically takes place between the long arms of acrocentric and chr 18 chromosomes, giving rise to a karyotype with 45 chromosomes.[20] Additional erasures 18p are the result of a partial trisomy for another chromosome and the malsegregation of a balanced paternal translocation with a variable breakpoint on 18p. Subtelomeric screening has revealed certain cryptic subtelomeric deletions or translocations.[21][22]

There have been at least six occurrences of documented familial transmission of 18p- from one parent to the kid, the majority of which included a maternal transfer.[23][24]

Sometimes 18p is deleted as part of the ring 18 chromosome,[25] and other times it results from recombination in a pericentric inversion that causes an 18p monosomy linked to an 18q trisomy.[26]

Diagnosis

edit

A definitive diagnosis of 18p deletion syndrome requires cytogenetic study, as the phenotype alone cannot be used to support the diagnosis.[27] Typically, peripheral blood karyotype analysis is used to make the diagnosis. It can also come from trophoblast cells or amniocytes during the perinatal stage.[1]

Many different syndromes that manifest as low stature and moderate mental impairment may be included in the differential diagnosis. Turner syndrome or trisomy 21 may be loosely associated with 18p deletion in young children. Cytogenetic analysis always enables the correct diagnosis.[27]

Treatment

edit

Like other chromosomal diseases, deletion 18p syndrome has no known specific treatment; however, since most patients experience significant speech issues and difficulties with speech articulation, early rehabilitative and educational interventions, primarily speech therapy, are advised. For hypotonia, physical therapy is often suggested.[1]

Outlook

edit

Patients with severe brain abnormalities typically have a poor prognosis and die during the neonatal period.[1] When severe abnormalities are absent, patients with the most prevalent form of deletion 18p syndrome do not appear to have a worse chance of survival.[28]

Epidemiology

edit

18p- occurs about once in 50,000 live births, with a female to male ratio of 3:1.[29]

References

edit
  1. ^ a b c d e f g h i j k l Turleau, Catherine (2008). "Monosomy 18p". Orphanet Journal of Rare Diseases. 3 (1): 4. doi:10.1186/1750-1172-3-4. ISSN 1750-1172. PMC 2265258. PMID 18284672.
  2. ^ Hasi-Zogaj M, Sebold C, Heard P, Carter E, Soileau B, Hill A, Rupert D, Perry B, Atkinson S, O'Donnell L, Gelfond J, Lancaster J, Fox PT, Hale DE, Cody JD (2015). "A review of 18p deletions". Am J Med Genet C Semin Med Genet. 169 (3): 251–64. doi:10.1002/ajmg.c.31445. PMID 26250845. S2CID 20556694.
  3. ^ Faust, J.; habedank, M.; Nieuwenhuijsen, C. (1976). "The 18 p- syndrome". European Journal of Pediatrics. 123 (1). Springer Science and Business Media LLC: 59–66. doi:10.1007/bf00497681. ISSN 0340-6997. PMID 954771.
  4. ^ Wester, Ulrika; Bondeson, Marie-Louise; Edeby, Christina; Annerén, Göran (2006-05-11). "Clinical and molecular characterization of individuals with 18p deletion: A genotype–phenotype correlation". American Journal of Medical Genetics Part A. 140A (11). Wiley: 1164–1171. doi:10.1002/ajmg.a.31260. ISSN 1552-4825. PMID 16691587.
  5. ^ Grosso, S.; Pucci, L.; Di Bartolo, R.M.; Gobbi, G.; Bartalini, G.; Anichini, C.; Scarinci, R.; Balestri, M.; Farnetani, M.A.; Cioni, M.; Morgese, G.; Balestri, P. (2005). "Chromosome 18 aberrations and epilepsy: A review". American Journal of Medical Genetics Part A. 134A (1). Wiley: 88–94. doi:10.1002/ajmg.a.30575. ISSN 1552-4825. PMID 15690352.
  6. ^ Cohen, M. Michael (2006). "Holoprosencephaly: Clinical, anatomic, and molecular dimensions". Birth Defects Research Part A: Clinical and Molecular Teratology. 76 (9). Wiley: 658–673. doi:10.1002/bdra.20295. ISSN 1542-0752. PMID 17001700.
  7. ^ a b Uchida, Irene A.; McRae, K. N.; Wang, H. C.; Ray, M. (2024-03-14). "Familial Short Arm Deficiency of Chromosome 18 Concomitant with Arhinencephaly and Alopecia Congenita". American Journal of Human Genetics. 17 (5). Elsevier: 410–419. PMC 1932656. PMID 14334740.
  8. ^ Münke, Maximilian; Page, David C.; Brown, Laura G.; Armson, B. Anthony; Zackai, Elaine H.; Mennuti, Michael T.; Emanuel, Beverly S. (1988). "Molecular detection of a Yp/18 translocation in a 45,X holoprosencephalic male". Human Genetics. 80 (3). Springer Science and Business Media LLC: 219–223. doi:10.1007/bf01790089. ISSN 0340-6717. PMID 3192211.
  9. ^ Overhauser, J; Mitchell, H F; Zackai, E H; Tick, D B; Rojas, K; Muenke, M (2024-03-14). "Physical mapping of the holoprosencephaly critical region in 18p11.3". American Journal of Human Genetics. 57 (5). Elsevier: 1080–1085. PMC 1801375. PMID 7485158.
  10. ^ Taine, L.; Goizet, C.; Wen, Z. Q.; Chateil, J. F.; Battin, J.; Saura, R.; Lacombe, D. (1997). "18p monosomy with midline defects and a de novo satellite identified by FISH". Annales de Génétique. 40 (3): 158–163. ISSN 0003-3995. PMID 9401105.
  11. ^ MC, Digilio; B, Marino; A, Giannotti; R, Di Donato; B, Dallapiccola (2000). "Heterotaxy with left atrial isomerism in a patient with deletion 18p". American Journal of Medical Genetics. 94 (3). Am J Med Genet: 198–200. doi:10.1002/1096-8628(20000918)94:3<198::aid-ajmg4>3.0.co;2-9. ISSN 0148-7299. PMID 10995505. Retrieved 2024-06-17.
  12. ^ Schober, E.; Scheibenreiter, S.; Frisch, H. (1995). "18p monosomy with GH-deficiency and empty sella: good response to GH-treatment". Clinical Genetics. 47 (5). Wiley: 254–256. doi:10.1111/j.1399-0004.1995.tb04306.x. ISSN 0009-9163. PMID 7554351.
  13. ^ Leisti, J; Leisti, S; Perheentupa, J; Savilahti, E; Aula, P (1973-04-01). "Absence of IgA and growth hormone deficiency associated with short arm deletion of chromosome 18". Archives of Disease in Childhood. 48 (4). BMJ: 320–322. doi:10.1136/adc.48.4.320. ISSN 0003-9888. PMC 1648328. PMID 4705937.
  14. ^ Dharmaraj, P; Grueters, A (2006). "The management of thyrotoxicosis in a pre-pubertal child with 18p deletion syndrome". European Journal of Endocrinology. 155 (suppl_1): S145–S147. doi:10.1530/eje.1.02274. ISSN 0804-4643.
  15. ^ Kantaputra, Piranit N.; Limwongse, Chanin; Tochareontanaphol, Chintana; Mutirangura, Apiwat; Mevatee, Umnat; Praphanphoj, Verayuth (2006-09-25). "Contiguous gene syndrome of holoprosencephaly and hypotrichosis simplex: Association with an 18p11.3 deletion". American Journal of Medical Genetics Part A. 140A (23). Wiley: 2598–2602. doi:10.1002/ajmg.a.31386. ISSN 1552-4825. PMID 17001671.
  16. ^ Nazarenko, S. A.; Ostroverkhova, N. V.; Vasiljeva, E. O.; Nazarenko, L. P.; Puzyrev, V. P.; Malet, P.; Nemtseva, T. A. (1999-07-16). "Keratosis pilaris and ulerythema ophryogenes associated with an 18p deletion caused by a Y/18 translocation". American Journal of Medical Genetics. 85 (2): 179–182. doi:10.1002/(SICI)1096-8628(19990716)85:2<179::AID-AJMG14>3.0.CO;2-R. ISSN 0148-7299. PMID 10406673.
  17. ^ ZOUBOULIS, C. C (2001-02-01). "Keratosis pilaris/ulerythema ophryogenes and 18p deletion: is it possible that the LAMA1 gene is involved?". Journal of Medical Genetics. 38 (2). BMJ: 127–128. doi:10.1136/jmg.38.2.127. ISSN 1468-6244. PMC 1734814. PMID 11288714.
  18. ^ Klein, C.; Page, C.E.; LeWitt, P.; Gordon, M.F.; de Leon, D.; Awaad, Y.; Breakefield, X.O.; Brin, M.F.; Ozelius, L.J. (1999). "Genetic analysis of three patients with an 18p− syndrome and dystonia". Neurology. 52 (3). Ovid Technologies (Wolters Kluwer Health): 649–651. doi:10.1212/wnl.52.3.649. ISSN 0028-3878. PMID 10025808.
  19. ^ Nasir, Jamal; Frima, Nafsika; Pickard, Ben; Malloy, M. Pat; Zhan, Lingping; Grünewald, Richard (2006-06-06). "Unbalanced whole arm translocation resulting in loss of 18p in dystonia". Movement Disorders. 21 (6). Wiley: 859–863. doi:10.1002/mds.20846. ISSN 0885-3185. PMID 16541453.
  20. ^ Wang, Jin-Chen C.; Nemana, L.; Kou, S. Y.; Habibian, R.; Hajianpour, M. J. (1997-09-05). "Molecular cytogenetic characterization of 18;21 whole arm translocation associated with monosomy 18p". American Journal of Medical Genetics. 71 (4): 463–466. doi:10.1002/(SICI)1096-8628(19970905)71:4<463::AID-AJMG17>3.0.CO;2-E. PMID 9286456.
  21. ^ Horsley, S W; Knight, S J; Nixon, J; Huson, S; Fitchett, M; Boone, R A; Hilton-Jones, D; Flint, J; Kearney, L (1998-09-01). "Del(18p) shown to be a cryptic translocation using a multiprobe FISH assay for subtelomeric chromosome rearrangements". Journal of Medical Genetics. 35 (9). BMJ: 722–726. doi:10.1136/jmg.35.9.722. ISSN 1468-6244. PMC 1051423. PMID 9733029.
  22. ^ Babovic-Vuksanovic, Dusica; Jenkins, S.C.; Ensenauer, R.; Newman, D.C.; Jalal, S.M. (2003-06-30). "Subtelomeric deletion of 18p in an adult with paranoid schizophrenia and mental retardation". American Journal of Medical Genetics Part A. 124A (3). Wiley: 318–322. doi:10.1002/ajmg.a.20391. ISSN 1552-4825. PMID 14708108.
  23. ^ Rigola, M.A.; Plaja, A.; Mediano, C.; Miro, R.; Egozcue, J.; Fuster, C. (2001). "Characterization of a heritable partial monosomy 18p by molecular and cytogenetic analysis". American Journal of Medical Genetics. 104 (1). Wiley: 37–41. doi:10.1002/ajmg.1584. ISSN 0148-7299. PMID 11746025.
  24. ^ Maranda, Bruno; Lemieux, Nicole; Lemyre, Emmanuelle (2006-07-14). "Familial deletion 18p syndrome: case report". BMC Medical Genetics. 7 (1). Springer Science and Business Media LLC: 60. doi:10.1186/1471-2350-7-60. ISSN 1471-2350. PMC 1540411. PMID 16842614.
  25. ^ P, Stankiewicz; I, Brozek; Z, Hélias-Rodzewicz; J, Wierzba; J, Pilch; E, Bocian; A, Balcerska; A, Wozniak; I, Kardaś; J, Wirth; T, Mazurczak; J, Limon (2001). "Clinical and molecular-cytogenetic studies in seven patients with ring chromosome 18". American Journal of Medical Genetics. 101 (3). Am J Med Genet: 226–239. doi:10.1002/1096-8628(20010701)101:3<226::aid-ajmg1349>3.0.co;2-#. ISSN 0148-7299. PMID 11424138. Retrieved 2024-06-17.
  26. ^ NJ, Leonard; DJ, Tomkins; N, Demianczuk (2000). "Prenatal diagnosis of holoprosencephaly (HPE) in a fetus with a recombinant (18)dup(18q)inv(18)(p11.31q11.2)mat". Prenatal Diagnosis. 20 (12). Prenat Diagn: 947–949. doi:10.1002/1097-0223(200012)20:12<947::aid-pd957>3.0.co;2-x. ISSN 0197-3851. PMID 11113905. Retrieved 2024-06-17.
  27. ^ a b Jain, Mayuri; Goyal, Megha; Singhal, Sachin; Nandimath, Kirty (2017). "18p deletion syndrome: Case report with clinical consideration and management". Contemporary Clinical Dentistry. 8 (4). Medknow: 632–636. doi:10.4103/ccd.ccd_129_17. ISSN 0976-237X. PMC 5754987. PMID 29326517.
  28. ^ de Ravel, Thomy J.L.; Thiry, Paul; Fryns, Jean-Pierre (2005). "Follow-up of adult males with chromosome 18p deletion". European Journal of Medical Genetics. 48 (2). Elsevier BV: 189–193. doi:10.1016/j.ejmg.2005.01.024. ISSN 1769-7212. PMID 16053911.
  29. ^ Choi, Ji Young; Moon, Ja Un; Yoon, Da Hye; Yim, Jisook; Kim, Myungshin; Jung, Min Ho (2022-07-01). "18p Deletion Syndrome Originating from Rare Unbalanced Whole-Arm Translocation between Chromosomes 13 and 18: A Case Report and Literature Review". Children. 9 (7). MDPI AG: 987. doi:10.3390/children9070987. ISSN 2227-9067. PMC 9316892. PMID 35883971.

Further reading

edit
  • Kasasbeh, Farhan A.; Shawabkeh, Montaha M.; Hawamdeh, Ali A. (2011). "Deletion of 18p Syndrome". Laboratory Medicine. 42 (7): 436–438. doi:10.1309/LMAPLK2TVJBX5K9M. ISSN 0007-5027.
  • Brenk, Christian H; Prott, Eva-Christina; Trost, Detlef; Hoischen, Alexander; Walldorf, Constanze; Radlwimmer, Bernhard; Wieczorek, Dagmar; Propping, Peter; Gillessen-Kaesbach, Gabriele; Weber, Ruthild G; Engels, Hartmut (2006-10-04). "Towards mapping phenotypical traits in 18p− syndrome by array-based comparative genomic hybridisation and fluorescent in situ hybridisation". European Journal of Human Genetics. 15 (1). Springer Science and Business Media LLC: 35–44. doi:10.1038/sj.ejhg.5201718. ISSN 1018-4813. PMID 17024214.
edit
Retrieved from "https://en.wikipedia.org/w/index.php?title=18p-&oldid=1243941526"